Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma

about

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma

Item

http://www.wikidata.org/entity/Q57494342

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@en

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@nl

type

Item

label

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@en

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@nl

prefLabel

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@en

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@nl

P1476

Antiviral therapy in hepatitis ...... diffuse large B cell lymphoma

@en

P2093

Adriano Pellicelli

http://www.w3.org/2001/XMLSchema#string

Anna Linda Zignego

http://www.w3.org/2001/XMLSchema#string

Valeria Pellicelli

http://www.w3.org/2001/XMLSchema#string

Valerio Giannelli

http://www.w3.org/2001/XMLSchema#string

Valerio Zoli

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

HCV and lymphoproliferation.

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma.

Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma.

Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.

P304

197-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/CEH.2018.78124

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30324145

http://www.w3.org/2001/XMLSchema#string

P932

6185930

http://www.w3.org/2001/XMLSchema#string